Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research
The Nutshell
Daily News Roundup
Most Recent
The US government has come out with new rules for life science research deemed risky.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
A new journal that publishes peer review comments alongside its manuscripts goes live.
Globally, 15-year-old girls outscored boys in 43 of the 65 countries tested.
Harvard geneticists and anthropologists challenge the work of two economists who say there’s a link between genetic diversity and wealth.
A new study disputes findings of a 2011 analysis suggesting that black researchers are funded less than their equally qualified white peers.
Researchers uncover more evidence that reprogrammed stem cells are not attacked by the immune system, suggesting they may one day serve as effective therapies.
After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.
Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
Subjects
- cell & molecular biology
- clinical trials
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
